EyePoint Pharmaceuticals, Inc. Quarterly Amortization of Intangible Assets in USD from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
EyePoint Pharmaceuticals, Inc. annual/quarterly Amortization of Intangible Assets history and growth rate from Q3 2010 to Q3 2023.
  • EyePoint Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2023 was $0.000, a 100% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $0.000, a 100% decline from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $2.05M, a 16.7% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2021 was $2.46M, unchanged from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 -$615K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q1 2023 $1.44M $0 -$615K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $2.05M $205K -$410K -66.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $2.46M $615K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $2.46M $615K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $2.46M $615K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $2.46M $615K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $2.46M $615K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $2.46M $615K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $2.46M $615K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $2.46M $615K $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $2.46M $615K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $2.46M $615K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $2.46M $615K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $2.46M $615K +$864K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $1.6M $615K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.6M $615K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $1.6M $615K +$615K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $981K -$249K -$432K -236% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $1.41M $615K +$433K +238% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $980K $615K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $0 -$180K -100% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $183K +$3K +1.67% Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-08
Q3 2017 $182K -$1K -0.55% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q1 2017 $730K $180K -$7K -3.74% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $737K $180K -$10K -5.26% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 $747K $183K -$9K -4.69% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $756K $187K -$4K -2.09% Apr 1, 2016 Jun 30, 2016 10-KT 2019-03-18
Q1 2016 $760K $187K -$3K -1.58% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $763K $190K -$3K -1.55% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $766K $192K -$4K -2.04% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $770K $191K -$5K -2.55% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-13
Q1 2015 $775K $190K -$6K -3.06% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $781K $193K -$1K -0.52% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $782K $196K +$4K +2.08% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $778K $196K +$6K +3.16% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-13
Q1 2014 $772K $196K +$4K +2.08% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $768K $194K $0 0% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 $768K $192K -$1K -0.52% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $769K $190K -$3K -1.55% Apr 1, 2013 Jun 30, 2013 10-K 2015-09-10
Q1 2013 $772K $192K $0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $772K $194K -$625K -76.3% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-12
Q3 2012 $1.4M $193K -$640K -76.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $2.04M $193K Apr 1, 2012 Jun 30, 2012 10-K 2014-09-11
Q1 2012 $192K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 $819K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-08
Q3 2011 $833K +$22K +2.71% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q3 2010 $811K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.